Get started
Author

Yoshiki Horie

Observed names: Horie, Y., Horie, Yoshiki, Y. Horie, YOSHIKI HORIE, 堀江 良樹, 堀江良樹
ORCID: 0000-0001-5568-6562
Observed ORCID: 0000-0001-5568-6562
OpenAlex ID: A5000250708
Randomized, Phase II Study of Trastuzumab Beyond Progression in Patients With HER2-Positive Advanced Gastric or Gastroesophageal Junction Cancer: WJOG7112G (T-ACT Study)
2020 · Akitaka Makiyama, Yasutaka Sukawa, et al. · Journal of Clinical Oncology · 200
Pulmonary Pleomorphic Carcinoma: A Clinicopathological Study Including EGFR Mutation Analysis
2010 · Kyoichi Kaira, Yoshiki Horie, et al. · Journal of Thoracic Oncology · 131
Phase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumors
2022 · Toshio Shimizu, Takako Eguchi Nakajima, et al. · Investigational New Drugs · 48
A randomized phase II study of weekly paclitaxel ± trastuzumab in patients with HER2-positive advanced gastric or gastro-esophageal junction cancer refractory to trastuzumab combined with fluoropyrimidine and platinum: WJOG7112G (T-ACT).
2018 · Akitaka Makiyama, Kosuke Sagara, et al. · Journal of Clinical Oncology · 36
A Phase II Study of Regorafenib With a Lower Starting Dose in Patients With Metastatic Colorectal Cancer: Exposure–Toxicity Analysis of Unbound Regorafenib and Its Active Metabolites (RESET Trial)
2019 · Takeshi Suzuki, Yasutaka Sukawa, et al. · Clinical Colorectal Cancer · 31
The Molecular Landscape of Pancreatobiliary Cancers for Novel Targeted Therapies From Real-World Genomic Profiling
2022 · Kumiko Umemoto, Hiroyuki Yamamoto, et al. · JNCI Journal of the National Cancer Institute · 29
PDF
Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
2024 · Jun Hamano, Takahiro Higashibata, et al. · Journal of Clinical Oncology · 24
Infusion site adverse events in breast cancer patients receiving highly emetic chemotherapy with prophylactic anti-emetic treatment with aprepitant and fosaprepitant: A retrospective comparison
2016 · TAKASHI TSUDA, CHISATO KYOMORI, et al. · Molecular and Clinical Oncology · 17
PDF
Early morphological change for predicting outcome in metastatic colorectal cancer after regorafenib
2017 · Hiroyuki Arai, Kunihisa Miyakawa, et al. · Oncotarget · 13
PDF
Impact of Body Weight Loss on Survival in Patients with Advanced Gastric Cancer Receiving Second-Line Treatment
2021 · Takuro Mizukami, Koki Hamaji, et al. · Nutrition and Cancer · 11
Identification of a FGFR3-TACC3 fusion in esophageal cancer
2016 · T. Mizukami, K. Sakai, et al. · Annals of Oncology · 11
PDF
Randomized phase II/III trial of gemcitabine plus nab-paclitaxel versus concurrent chemoradiotherapy with S-1 as neoadjuvant treatment for borderline resectable pancreatic cancer: GABARNANCE study.
2024 · Masafumi Ikeda, Shogo Nomura, et al. · Journal of Clinical Oncology · 10
PDF
Clinical utility of geriatric assessment tools in older patients with gastrointestinal cancer
2023 · Ayako Doi, Takuro Mizukami, et al. · Frontiers in Oncology · 9
Current status of integrating oncology and palliative care in Japan: a nationwide survey
2020 · Y. Uneno, K. Sato, et al. · BMC Palliative Care · 9
PDF
Antibiotics may enhance the efficacy of gemcitabine treatment for advanced pancreatic cancer
2018 · Y. Sunakawa, H. Arai, et al. · Annals of Oncology · 7
Clinical Utility of Genomic Profiling Tests in Patients with Advanced Gastrointestinal Cancers
2022 · Hiroyuki Takeda, Kiyomi Imoto, et al. · Targeted Oncology · 6
Inferior mesenteric arteriovenous fistula during treatment with bevacizumab in colorectal cancer patient: A case report
2020 · Ayako Doi, Hiroyuki Takeda, et al. · World Journal of Gastrointestinal Oncology · 6
Analysis of fistula formation of T4 esophageal cancer patients treated by chemoradiotherapy
2019 · Tomoko Katsui Taniyama, Takashi Tsuda, et al. · Esophagus · 6
Profile of trifluridine/tipiracil hydrochloride in the treatment of metastatic colorectal cancer: efficacy, safety, and place in therapy
2017 · Yu Sunakawa, Naoki Izawa, et al. · OncoTargets and Therapy · 6
PDF
Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancer
2020 · Yosuke Kito, Hironaga Satake, et al. · Cancer Chemotherapy and Pharmacology · 5
Feasibility of edoxaban for asymptomatic cancer-associated thrombosis in Japanese patients with gastrointestinal cancer: ExCAVE study
2022 · Michio Nakamura, Atsushi Ishiguro, et al. · BMC Cancer · 4
PDF
T-ACT (WJOG7112G): A randomized phase II study of weekly paclitaxel ± trastuzumab in patients with HER2-positive advanced gastric or gastro-esophageal junction cancer refractory to trastuzumab combined with fluoropyrimidine and platinum.
2017 · Taito Esaki, Akitaka Makiyama, et al. · Journal of Clinical Oncology · 4
Rationale and design of a multicenter, double-blinded, randomized, placebo-controlled trial to investigate the effects of naldemedine on opioid-induced constipation for patients with cancer pain: A study protocol
2022 · Takahiro Higashibata, Jun Hamano, et al. · Contemporary Clinical Trials Communications · 3
PDF
An Observational Study on Nutrition Status in Gastric Cancer Patients Receiving Ramucirumab Plus Taxane: BALAST Study
2021 · Takuro Mizukami, Tempei Miyaji, et al. · Future Oncology · 3
Association of gastric acid suppression with efficacy of immune checkpoint inhibitors (ICIs) in advanced cancer patients
2019 · Naoki Izawa, Hisae Shiokawa, et al. · Annals of Oncology · 3
Works count: 91
Citation count: 654
H-index: 11
I10-index: 12
Year
Topic
Type